The Relationship Between Cold Water Immersion and the Progression in Gout Arthritis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04587544 |
|
Recruitment Status :
Completed
First Posted : October 14, 2020
Last Update Posted : March 17, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Gout Arthritis | Behavioral: Cold Water Immersion | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 76 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The randomized control trial study with two parallel-intervention-groups was employed to examine the effect of CWI (20-30C) therapy. All participants were randomly assigned to either CWI (20-30C) therapy intervention group or the control group. Block random sampling was then employed to generate the intervention and control group sequence. All participants were assessed on their pain as the primary outcome, joint mobility, stress, anxiety, depression, QOL (included PCS and MCS), physical activity (MET-h/week) at three times points: before the intervention, 2nd and 4th-week of the intervention. |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Due to the nature of the intervention, it is only possible to blind the evaluator of the study. The evaluator is blinded the group division either treatment or control group. |
| Primary Purpose: | Treatment |
| Official Title: | Effect of a Cold Water Immersion (CWI) on Pain in People With Gouty Arthritis: A Community Based Randomized Controlled Trial |
| Actual Study Start Date : | July 1, 2019 |
| Actual Primary Completion Date : | January 1, 2021 |
| Actual Study Completion Date : | January 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Cold Water Immersion
The participants maintained their daily activities during the intervention. When daily activity ended, the intervention was begun. CWI therapy by immersed the whole part of inflamed target joints in the water at 20-30C for 20 minutes/day. The intervention was continued for four weeks. The researchers work together with the nurses of community health services to give the intervention.
|
Behavioral: Cold Water Immersion
The participants maintained their daily activities during the intervention. When daily activity ended, the intervention was begun. CWI therapy by immersed the whole part of inflamed target joints in the water at 20-30C for 20 minutes/day. The intervention was continued for four weeks. The researchers work together with the nurses of community health services to give the intervention. |
|
No Intervention: No Intervention
The participants would not receive Cold Water Intervention. However, they are allowed to received the usual care
|
- Pain Level assessed by The Visual Analog Scale (VAS) at the baseline [ Time Frame: Baseline/ pre-intervention ]Pain Level assessed by the Visual Analog Scale (VAS) instrument that has 10 centimeters length. The standard scale anchored by "no pain" marked as a score of 0 and the "worst imaginable pain" marked as a score of 10 cm (Huskisson et al., 1974; Scott & Huskisson, 1976). The higher score identifies greater pain intensity. The reliability test showed that VAS was good (r = 0.94, p = 0.001) (Ferraz et al., 1990). The reliability test of the VAS instrument has been done in Indonesia with the Cronbach's alpha as 0.89 (Suwendar et al., 2017)
- Pain Level assessed by The Visual Analog Scale (VAS) at the 2nd week/during the intervention [ Time Frame: 2nd week/during the intervention ]Pain Level assessed by The Visual Analog Scale (VAS) instrument that has 10 centimeters length. The standard scale anchored by "no pain" marked as a score of 0 and the "worst imaginable pain" marked as a score of 10 cm (Huskisson et al., 1974; Scott & Huskisson, 1976). The higher score identifies greater pain intensity. The reliability test showed that VAS was good (r = 0.94, p = 0.001) (Ferraz et al., 1990). The reliability test of the VAS instrument has been done in Indonesia with the Cronbach's alpha as 0.89 (Suwendar et al., 2017)
- Pain Level assessed by the Visual Analog Scale (VAS) at 4th week/immediately after intervention [ Time Frame: 4th week/immediately after intervention ]Pain Level assessed by the Visual Analog Scale (VAS) instrument has 10 centimeters length. The standard scale anchored by "no pain" marked as a score of 0 and the "worst imaginable pain" marked as a score of 10 cm (Huskisson et al., 1974; Scott & Huskisson, 1976). The higher score identifies greater pain intensity. The reliability test showed that VAS was good (r = 0.94, p = 0.001) (Ferraz et al., 1990). The reliability test of the VAS instrument has been done in Indonesia with the Cronbach's alpha as 0.89 (Suwendar et al., 2017)
- Joint mobility assessed by Goniometry at the baseline [ Time Frame: Baseline/ pre-intervention ]Joint mobility assessed by Goniometry. The range of knee joint motion was calculated using an International Standard Orthopedic Measurement (ISOM) goniometric. Its method using the Sagittal Frontal Transverse Rotation (SFTR) system to an accuracy of 10 (Dorwart, Hansell, & Schumacher, 1974). Goniometry provides an objective assessment tool to measure the range of motion (Rose & Norton, 1987). The validity and reliability of Goniometry are 0.98 and 0.97, respectively (Rose & Norton, 1987). The validity score of the Indonesian version is 0.97, and the Cronbach alpha as 0.51 (Hafiyah, 2013).
- Joint mobility assessed by Goniometry at the 2nd week/during the intervention [ Time Frame: 2nd week/during the intervention ]Joint mobility assessed by Goniometry. The range of knee joint motion was calculated using an International Standard Orthopedic Measurement (ISOM) goniometric. Its method using the Sagittal Frontal Transverse Rotation (SFTR) system to an accuracy of 10 (Dorwart, Hansell, & Schumacher, 1974). Goniometry provides an objective assessment tool to measure the range of motion (Rose & Norton, 1987). The validity and reliability of Goniometry are 0.98 and 0.97, respectively (Rose & Norton, 1987). The validity score of the Indonesian version is 0.97, and the Cronbach alpha as 0.51 (Hafiyah, 2013).
- Joint mobility assessed by Goniometry at the 4th week/immediately after intervention [ Time Frame: 4th week/immediately after intervention ]Joint mobility assessed by Goniometry. The range of knee joint motion was calculated using an International Standard Orthopedic Measurement (ISOM) goniometric. Its method using the Sagittal Frontal Transverse Rotation (SFTR) system to an accuracy of 10 (Dorwart, Hansell, & Schumacher, 1974). Goniometry provides an objective assessment tool to measure the range of motion (Rose & Norton, 1987). The validity and reliability of Goniometry are 0.98 and 0.97, respectively (Rose & Norton, 1987). The validity score of the Indonesian version is 0.97, and the Cronbach alpha as 0.51 (Hafiyah, 2013).
- Stress, anxiety, depression assessed by The Depression Anxiety Stress Scale questionnaire at the baseline [ Time Frame: Baseline/ pre-intervention ]The Depression Anxiety Stress Scale questionnaire is used to measure the negative states of three mental health conditions: depression, anxiety, and stress using a self-report 4-point Likert scale. Data was collected by reflects the thoughts, feelings, and behavior (Oei, Sawang, Goh, & Mukhtar, 2013). The result will be defined by the total scores of responses from the 7-item subscale of this questionnaire. The lower score shows a better result. If the total number of depressions is 9 or below and the extremely severe is 34 or over. The Cronbach's alphas of Indonesian translated is 0.72 to 0.87 (Susilowati, Isahak, & Harncharoen, 2016).
- Stress, anxiety, depression assessed by The Depression Anxiety Stress Scale questionnaire at the 2nd week/during the intervention [ Time Frame: 2nd week/during the intervention ]The Depression Anxiety Stress Scale questionnaire is used to measure the negative states of three mental health conditions: depression, anxiety, and stress using a self-report 4-point Likert scale. Data was collected by reflects the thoughts, feelings, and behavior (Oei, Sawang, Goh, & Mukhtar, 2013). The result will be defined by the total scores of responses from the 7-item subscale of this questionnaire. The lower score shows a better result. If the total number of depressions is 9 or below and the extremely severe is 34 or over. The Cronbach's alphas of Indonesian translated is 0.72 to 0.87 (Susilowati, Isahak, & Harncharoen, 2016).
- Stress, anxiety, depression assessed by the Depression Anxiety Stress Scale at 4th week/immediately after intervention [ Time Frame: 4th week/immediately after intervention ]The Depression Anxiety Stress Scale questionnaire is used to measure the negative states of three mental health conditions: depression, anxiety, and stress using a self-report 4-point Likert scale. Data was collected by reflects the thoughts, feelings, and behavior (Oei, Sawang, Goh, & Mukhtar, 2013). The result will be defined by the total scores of responses from the 7-item subscale of this questionnaire. The lower score shows a better result. If the total number of depressions is 9 or below and the extremely severe is 34 or over. The Cronbach's alphas of Indonesian translated is 0.72 to 0.87 (Susilowati, Isahak, & Harncharoen, 2016).
- Quality of Life (QOL) level assessed by 36 Health Survey (SF-36) questionnaire at Baseline [ Time Frame: Baseline, pre-intervention ]Quality of Life (QOL) level assessed by 36 Health Survey (SF-36) questionnaire that was employed to estimate QOL. It included Physical Component Summary (PCS), Mental Component Summary (MCS). Total QOL range from 0 to 100 (Rias et al., 2020). The Indonesia version of the SF-36 questionnaire has tested the reliability with the Cronbach's alphas 0.7 (Salim, Yamin, Alwi, & Setiati, 2015)
- Quality of Life (QOL) level assessed by 36 Health Survey (SF-36) questionnaire 2nd week/during the intervention [ Time Frame: 2nd week/during the intervention ]Quality of Life (QOL) level assessed by 36 Health Survey (SF-36) questionnaire that was employed to estimate QOL. It included Physical Component Summary (PCS), Mental Component Summary (MCS). Total QOL range from 0 to 100 (Rias et al., 2020). The Indonesia version of the SF-36 questionnaire has tested the reliability with the Cronbach's alphas 0.7 (Salim, Yamin, Alwi, & Setiati, 2015)
- Quality of Life (QOL) level assessed by36 Health Survey (SF-36) questionnaire 4th week/immediately after intervention [ Time Frame: 4th week/immediately after intervention ]Quality of Life (QOL) level assessed by 36 Health Survey (SF-36) questionnaire that was employed to estimate QOL. It included Physical Component Summary (PCS), Mental Component Summary (MCS). Total QOL range from 0 to 100 (Rias et al., 2020). The Indonesia version of the SF-36 questionnaire has tested the reliability with the Cronbach's alphas 0.7 (Salim, Yamin, Alwi, & Setiati, 2015)
- Physical activity (MET-h/week) level assessed by questions based on the modified Physical Activity Guideline at the baseline [ Time Frame: Baseline, pre-intervention ]The physical activity level was investigated as metabolic equivalent of task (MET)-hr/week by using three questions based on the modified Physical Activity Guideline from the Advisory Committee for Americans (Shiroma, Sesso, Moorthy, Buring, & Lee, 2015) and the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1997). We then categorized participants based on the exercise type (that is divided into the following categories: mild (e.g., yoga, bowling, or floor-sweeping), moderate (e.g., gym, baseball, or badminton), and strenuous exercise (e.g., hiking, soccer, or running)), duration in minutes and exercise intensity they presented during a typical week. We multiplied the amount of mild, moderate, and strenuous exercise hours and duration by 3, 5, and 9, respectively. By summing the exercise pattern of the separate things, we measured total weekly PA in arbitrary units (Rias et al., 2020).
- Physical activity (MET-h/week) level assessed by questions based on the modified Physical Activity Guideline at 2nd week/during the intervention [ Time Frame: 2nd week/during the intervention ]The physical activity level was investigated as metabolic equivalent of task (MET)-hr/week by using three questions based on the modified Physical Activity Guideline from the Advisory Committee for Americans (Shiroma, Sesso, Moorthy, Buring, & Lee, 2015) and the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1997). We then categorized participants based on the exercise type (that is divided into the following categories: mild (e.g., yoga, bowling, or floor-sweeping), moderate (e.g., gym, baseball, or badminton), and strenuous exercise (e.g., hiking, soccer, or running)), duration in minutes and exercise intensity they presented during a typical week. We multiplied the amount of mild, moderate, and strenuous exercise hours and duration by 3, 5, and 9, respectively. By summing the exercise pattern of the separate things, we measured total weekly PA in arbitrary units (Rias et al., 2020).
- Physical activity (MET-h/week) level: Change from Baseline and 2nd week time point [ Time Frame: 4th week/immediately after intervention ]The physical activity level was investigated as metabolic equivalent of task (MET)-hr/week by using three questions based on the modified Physical Activity Guideline from the Advisory Committee for Americans (Shiroma, Sesso, Moorthy, Buring, & Lee, 2015) and the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 1997). We then categorized participants based on the exercise type (that is divided into the following categories: mild (e.g., yoga, bowling, or floor-sweeping), moderate (e.g., gym, baseball, or badminton), and strenuous exercise (e.g., hiking, soccer, or running)), duration in minutes and exercise intensity they presented during a typical week. We multiplied the amount of mild, moderate, and strenuous exercise hours and duration by 3, 5, and 9, respectively. By summing the exercise pattern of the separate things, we measured total weekly PA in arbitrary units (Rias et al., 2020).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- People with gouty arthritis in the knee or ankle or metatarsophalangeal or metacarpophalangeal or olecranon bursa or wrist
- Participants were Indonesian nationals aged ≥18 years
- They had visited a clinic of the Public CHS of Tomohon City
- They had agreed to participate in the study.
Exclusion Criteria:
- Participants who self-reported the presence of other types of inflammatory arthritis, including RA or spondyloarthritis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04587544
| Indonesia | |
| Rendra | |
| Tomohon, North Celebes, Indonesia, 95446 | |
| Study Director: | Hsiu Ting Tsai, PhD | Taipei Medical University |
Documents provided by Maria Dyah Kurniasari, Taipei Medical University:
| Responsible Party: | Maria Dyah Kurniasari, College of Nursing, Taipei Medical University, Taipei, Taiwan, R.O.C., Taipei Medical University |
| ClinicalTrials.gov Identifier: | NCT04587544 |
| Other Study ID Numbers: |
N201912052 |
| First Posted: | October 14, 2020 Key Record Dates |
| Last Update Posted: | March 17, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Gout Arthritis Cold Water Immersion Pain |
|
Arthritis Arthritis, Gouty Joint Diseases Musculoskeletal Diseases Gout Crystal Arthropathies |
Rheumatic Diseases Purine-Pyrimidine Metabolism, Inborn Errors Metabolism, Inborn Errors Genetic Diseases, Inborn Metabolic Diseases |

